Global Androgenetic Alopecia Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 44727
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Androgenetic Alopecia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Androgenetic Alopecia Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Androgenetic Alopecia Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Androgenetic Alopecia Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Topical Agents

5 AR Inhibitors

Others

Market segment by Application, can be divided into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Market segment by players, this report covers

Histogen Inc

Cipla Limited

Aclaris Therapeutics, Inc

Merck & Co., Inc

Daiichi-Sankyo Co., Ltd

Johnson and Johnson Services, Inc

Lexington International LLC

Vita-Cos-Med Klett-Loch GmbH

PureTech

Vitabiotics

Dr. Reddy’s Laboratories

HCell Inc

Follica, Inc

Ranbaxy Laboratories Ltd.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Androgenetic Alopecia Treatment

1.2 Classification of Androgenetic Alopecia Treatment by Type

1.2.1 Overview: Global Androgenetic Alopecia Treatment Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Androgenetic Alopecia Treatment Revenue Market Share by Type in 2020

1.2.3 Topical Agents

1.2.4 5 AR Inhibitors

1.2.5 Others

1.3 Global Androgenetic Alopecia Treatment Market by Application

1.3.1 Overview: Global Androgenetic Alopecia Treatment Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Androgenetic Alopecia Treatment Market Size & Forecast

1.5 Global Androgenetic Alopecia Treatment Market Size and Forecast by Region

1.5.1 Global Androgenetic Alopecia Treatment Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Androgenetic Alopecia Treatment Market Size by Region, (2016-2021)

1.5.3 North America Androgenetic Alopecia Treatment Market Size and Prospect (2016-2026)

1.5.4 Europe Androgenetic Alopecia Treatment Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Androgenetic Alopecia Treatment Market Size and Prospect (2016-2026)

1.5.6 South America Androgenetic Alopecia Treatment Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Androgenetic Alopecia Treatment Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Androgenetic Alopecia Treatment Market Drivers

1.6.2 Androgenetic Alopecia Treatment Market Restraints

1.6.3 Androgenetic Alopecia Treatment Trends Analysis

2 Company Profiles

2.1 Histogen Inc

2.1.1 Histogen Inc Details

2.1.2 Histogen Inc Major Business

2.1.3 Histogen Inc Androgenetic Alopecia Treatment Product and Solutions

2.1.4 Histogen Inc Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Histogen Inc Recent Developments and Future Plans

2.2 Cipla Limited

2.2.1 Cipla Limited Details

2.2.2 Cipla Limited Major Business

2.2.3 Cipla Limited Androgenetic Alopecia Treatment Product and Solutions

2.2.4 Cipla Limited Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Cipla Limited Recent Developments and Future Plans

2.3 Aclaris Therapeutics, Inc

2.3.1 Aclaris Therapeutics, Inc Details

2.3.2 Aclaris Therapeutics, Inc Major Business

2.3.3 Aclaris Therapeutics, Inc Androgenetic Alopecia Treatment Product and Solutions

2.3.4 Aclaris Therapeutics, Inc Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Aclaris Therapeutics, Inc Recent Developments and Future Plans

2.4 Merck & Co., Inc

2.4.1 Merck & Co., Inc Details

2.4.2 Merck & Co., Inc Major Business

2.4.3 Merck & Co., Inc Androgenetic Alopecia Treatment Product and Solutions

2.4.4 Merck & Co., Inc Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Merck & Co., Inc Recent Developments and Future Plans

2.5 Daiichi-Sankyo Co., Ltd

2.5.1 Daiichi-Sankyo Co., Ltd Details

2.5.2 Daiichi-Sankyo Co., Ltd Major Business

2.5.3 Daiichi-Sankyo Co., Ltd Androgenetic Alopecia Treatment Product and Solutions

2.5.4 Daiichi-Sankyo Co., Ltd Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Daiichi-Sankyo Co., Ltd Recent Developments and Future Plans

2.6 Johnson and Johnson Services, Inc

2.6.1 Johnson and Johnson Services, Inc Details

2.6.2 Johnson and Johnson Services, Inc Major Business

2.6.3 Johnson and Johnson Services, Inc Androgenetic Alopecia Treatment Product and Solutions

2.6.4 Johnson and Johnson Services, Inc Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Johnson and Johnson Services, Inc Recent Developments and Future Plans

2.7 Lexington International LLC

2.7.1 Lexington International LLC Details

2.7.2 Lexington International LLC Major Business

2.7.3 Lexington International LLC Androgenetic Alopecia Treatment Product and Solutions

2.7.4 Lexington International LLC Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Lexington International LLC Recent Developments and Future Plans

2.8 Vita-Cos-Med Klett-Loch GmbH

2.8.1 Vita-Cos-Med Klett-Loch GmbH Details

2.8.2 Vita-Cos-Med Klett-Loch GmbH Major Business

2.8.3 Vita-Cos-Med Klett-Loch GmbH Androgenetic Alopecia Treatment Product and Solutions

2.8.4 Vita-Cos-Med Klett-Loch GmbH Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Vita-Cos-Med Klett-Loch GmbH Recent Developments and Future Plans

2.9 PureTech

2.9.1 PureTech Details

2.9.2 PureTech Major Business

2.9.3 PureTech Androgenetic Alopecia Treatment Product and Solutions

2.9.4 PureTech Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 PureTech Recent Developments and Future Plans

2.10 Vitabiotics

2.10.1 Vitabiotics Details

2.10.2 Vitabiotics Major Business

2.10.3 Vitabiotics Androgenetic Alopecia Treatment Product and Solutions

2.10.4 Vitabiotics Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Vitabiotics Recent Developments and Future Plans

2.11 Dr. Reddy’s Laboratories

2.11.1 Dr. Reddy’s Laboratories Details

2.11.2 Dr. Reddy’s Laboratories Major Business

2.11.3 Dr. Reddy’s Laboratories Androgenetic Alopecia Treatment Product and Solutions

2.11.4 Dr. Reddy’s Laboratories Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Dr. Reddy’s Laboratories Recent Developments and Future Plans

2.12 HCell Inc

2.12.1 HCell Inc Details

2.12.2 HCell Inc Major Business

2.12.3 HCell Inc Androgenetic Alopecia Treatment Product and Solutions

2.12.4 HCell Inc Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 HCell Inc Recent Developments and Future Plans

2.13 Follica, Inc

2.13.1 Follica, Inc Details

2.13.2 Follica, Inc Major Business

2.13.3 Follica, Inc Androgenetic Alopecia Treatment Product and Solutions

2.13.4 Follica, Inc Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Follica, Inc Recent Developments and Future Plans

2.14 Ranbaxy Laboratories Ltd.

2.14.1 Ranbaxy Laboratories Ltd. Details

2.14.2 Ranbaxy Laboratories Ltd. Major Business

2.14.3 Ranbaxy Laboratories Ltd. Androgenetic Alopecia Treatment Product and Solutions

2.14.4 Ranbaxy Laboratories Ltd. Androgenetic Alopecia Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Ranbaxy Laboratories Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Androgenetic Alopecia Treatment Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Androgenetic Alopecia Treatment Players Market Share

3.2.2 Top 10 Androgenetic Alopecia Treatment Players Market Share

3.2.3 Market Competition Trend

3.3 Androgenetic Alopecia Treatment Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Androgenetic Alopecia Treatment Revenue and Market Share by Type (2016-2021)

4.2 Global Androgenetic Alopecia Treatment Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Androgenetic Alopecia Treatment Revenue Market Share by Application (2016-2021)

5.2 Androgenetic Alopecia Treatment Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Androgenetic Alopecia Treatment Revenue by Type (2016-2026)

6.2 North America Androgenetic Alopecia Treatment Revenue by Application (2016-2026)

6.3 North America Androgenetic Alopecia Treatment Market Size by Country

6.3.1 North America Androgenetic Alopecia Treatment Revenue by Country (2016-2026)

6.3.2 United States Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

6.3.3 Canada Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

6.3.4 Mexico Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Androgenetic Alopecia Treatment Revenue by Type (2016-2026)

7.2 Europe Androgenetic Alopecia Treatment Revenue by Application (2016-2026)

7.3 Europe Androgenetic Alopecia Treatment Market Size by Country

7.3.1 Europe Androgenetic Alopecia Treatment Revenue by Country (2016-2026)

7.3.2 Germany Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

7.3.3 France Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

7.3.5 Russia Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

7.3.6 Italy Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Androgenetic Alopecia Treatment Revenue by Type (2016-2026)

8.2 Asia-Pacific Androgenetic Alopecia Treatment Revenue by Application (2016-2026)

8.3 Asia-Pacific Androgenetic Alopecia Treatment Market Size by Region

8.3.1 Asia-Pacific Androgenetic Alopecia Treatment Revenue by Region (2016-2026)

8.3.2 China Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

8.3.3 Japan Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

8.3.4 South Korea Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

8.3.5 India Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

8.3.7 Australia Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Androgenetic Alopecia Treatment Revenue by Type (2016-2026)

9.2 South America Androgenetic Alopecia Treatment Revenue by Application (2016-2026)

9.3 South America Androgenetic Alopecia Treatment Market Size by Country

9.3.1 South America Androgenetic Alopecia Treatment Revenue by Country (2016-2026)

9.3.2 Brazil Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

9.3.3 Argentina Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Androgenetic Alopecia Treatment Revenue by Type (2016-2026)

10.2 Middle East & Africa Androgenetic Alopecia Treatment Revenue by Application (2016-2026)

10.3 Middle East & Africa Androgenetic Alopecia Treatment Market Size by Country

10.3.1 Middle East & Africa Androgenetic Alopecia Treatment Revenue by Country (2016-2026)

10.3.2 Turkey Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

10.3.4 UAE Androgenetic Alopecia Treatment Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Androgenetic Alopecia Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Androgenetic Alopecia Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Androgenetic Alopecia Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Androgenetic Alopecia Treatment Revenue (USD Million) by Region (2016-2021)

Table 5. Global Androgenetic Alopecia Treatment Revenue Market Share by Region (2021-2026)

Table 6. Histogen Inc Corporate Information, Head Office, and Major Competitors

Table 7. Histogen Inc Major Business

Table 8. Histogen Inc Androgenetic Alopecia Treatment Product and Solutions

Table 9. Histogen Inc Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Cipla Limited Corporate Information, Head Office, and Major Competitors

Table 11. Cipla Limited Major Business

Table 12. Cipla Limited Androgenetic Alopecia Treatment Product and Solutions

Table 13. Cipla Limited Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Aclaris Therapeutics, Inc Corporate Information, Head Office, and Major Competitors

Table 15. Aclaris Therapeutics, Inc Major Business

Table 16. Aclaris Therapeutics, Inc Androgenetic Alopecia Treatment Product and Solutions

Table 17. Aclaris Therapeutics, Inc Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Merck & Co., Inc Corporate Information, Head Office, and Major Competitors

Table 19. Merck & Co., Inc Major Business

Table 20. Merck & Co., Inc Androgenetic Alopecia Treatment Product and Solutions

Table 21. Merck & Co., Inc Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Daiichi-Sankyo Co., Ltd Corporate Information, Head Office, and Major Competitors

Table 23. Daiichi-Sankyo Co., Ltd Major Business

Table 24. Daiichi-Sankyo Co., Ltd Androgenetic Alopecia Treatment Product and Solutions

Table 25. Daiichi-Sankyo Co., Ltd Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Johnson and Johnson Services, Inc Corporate Information, Head Office, and Major Competitors

Table 27. Johnson and Johnson Services, Inc Major Business

Table 28. Johnson and Johnson Services, Inc Androgenetic Alopecia Treatment Product and Solutions

Table 29. Johnson and Johnson Services, Inc Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Lexington International LLC Corporate Information, Head Office, and Major Competitors

Table 31. Lexington International LLC Major Business

Table 32. Lexington International LLC Androgenetic Alopecia Treatment Product and Solutions

Table 33. Lexington International LLC Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Vita-Cos-Med Klett-Loch GmbH Corporate Information, Head Office, and Major Competitors

Table 35. Vita-Cos-Med Klett-Loch GmbH Major Business

Table 36. Vita-Cos-Med Klett-Loch GmbH Androgenetic Alopecia Treatment Product and Solutions

Table 37. Vita-Cos-Med Klett-Loch GmbH Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. PureTech Corporate Information, Head Office, and Major Competitors

Table 39. PureTech Major Business

Table 40. PureTech Androgenetic Alopecia Treatment Product and Solutions

Table 41. PureTech Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Vitabiotics Corporate Information, Head Office, and Major Competitors

Table 43. Vitabiotics Major Business

Table 44. Vitabiotics Androgenetic Alopecia Treatment Product and Solutions

Table 45. Vitabiotics Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Dr. Reddy’s Laboratories Corporate Information, Head Office, and Major Competitors

Table 47. Dr. Reddy’s Laboratories Major Business

Table 48. Dr. Reddy’s Laboratories Androgenetic Alopecia Treatment Product and Solutions

Table 49. Dr. Reddy’s Laboratories Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. HCell Inc Corporate Information, Head Office, and Major Competitors

Table 51. HCell Inc Major Business

Table 52. HCell Inc Androgenetic Alopecia Treatment Product and Solutions

Table 53. HCell Inc Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Follica, Inc Corporate Information, Head Office, and Major Competitors

Table 55. Follica, Inc Major Business

Table 56. Follica, Inc Androgenetic Alopecia Treatment Product and Solutions

Table 57. Follica, Inc Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Ranbaxy Laboratories Ltd. Corporate Information, Head Office, and Major Competitors

Table 59. Ranbaxy Laboratories Ltd. Major Business

Table 60. Ranbaxy Laboratories Ltd. Androgenetic Alopecia Treatment Product and Solutions

Table 61. Ranbaxy Laboratories Ltd. Androgenetic Alopecia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Global Androgenetic Alopecia Treatment Revenue (USD Million) by Players (2019-2021)

Table 63. Global Androgenetic Alopecia Treatment Revenue Share by Players (2019-2021)

Table 64. Breakdown of Androgenetic Alopecia Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Androgenetic Alopecia Treatment Players Head Office, Products and Services Provided

Table 66. Androgenetic Alopecia Treatment Mergers & Acquisitions in the Past Five Years

Table 67. Androgenetic Alopecia Treatment New Entrants and Expansion Plans

Table 68. Global Androgenetic Alopecia Treatment Revenue (USD Million) by Type (2016-2021)

Table 69. Global Androgenetic Alopecia Treatment Revenue Share by Type (2016-2021)

Table 70. Global Androgenetic Alopecia Treatment Revenue Forecast by Type (2021-2026)

Table 71. Global Androgenetic Alopecia Treatment Revenue by Application (2016-2021)

Table 72. Global Androgenetic Alopecia Treatment Revenue Forecast by Application (2021-2026)

Table 73. North America Androgenetic Alopecia Treatment Revenue by Type (2016-2021) & (USD Million)

Table 74. North America Androgenetic Alopecia Treatment Revenue by Type (2021-2026) & (USD Million)

Table 75. North America Androgenetic Alopecia Treatment Revenue by Application (2016-2021) & (USD Million)

Table 76. North America Androgenetic Alopecia Treatment Revenue by Application (2021-2026) & (USD Million)

Table 77. North America Androgenetic Alopecia Treatment Revenue by Country (2016-2021) & (USD Million)

Table 78. North America Androgenetic Alopecia Treatment Revenue by Country (2021-2026) & (USD Million)

Table 79. Europe Androgenetic Alopecia Treatment Revenue by Type (2016-2021) & (USD Million)

Table 80. Europe Androgenetic Alopecia Treatment Revenue by Type (2021-2026) & (USD Million)

Table 81. Europe Androgenetic Alopecia Treatment Revenue by Application (2016-2021) & (USD Million)

Table 82. Europe Androgenetic Alopecia Treatment Revenue by Application (2021-2026) & (USD Million)

Table 83. Europe Androgenetic Alopecia Treatment Revenue by Country (2016-2021) & (USD Million)

Table 84. Europe Androgenetic Alopecia Treatment Revenue by Country (2021-2026) & (USD Million)

Table 85. Asia-Pacific Androgenetic Alopecia Treatment Revenue by Type (2016-2021) & (USD Million)

Table 86. Asia-Pacific Androgenetic Alopecia Treatment Revenue by Type (2021-2026) & (USD Million)

Table 87. Asia-Pacific Androgenetic Alopecia Treatment Revenue by Application (2016-2021) & (USD Million)

Table 88. Asia-Pacific Androgenetic Alopecia Treatment Revenue by Application (2021-2026) & (USD Million)

Table 89. Asia-Pacific Androgenetic Alopecia Treatment Revenue by Region (2016-2021) & (USD Million)

Table 90. Asia-Pacific Androgenetic Alopecia Treatment Revenue by Region (2021-2026) & (USD Million)

Table 91. South America Androgenetic Alopecia Treatment Revenue by Type (2016-2021) & (USD Million)

Table 92. South America Androgenetic Alopecia Treatment Revenue by Type (2021-2026) & (USD Million)

Table 93. South America Androgenetic Alopecia Treatment Revenue by Application (2016-2021) & (USD Million)

Table 94. South America Androgenetic Alopecia Treatment Revenue by Application (2021-2026) & (USD Million)

Table 95. South America Androgenetic Alopecia Treatment Revenue by Country (2016-2021) & (USD Million)

Table 96. South America Androgenetic Alopecia Treatment Revenue by Country (2021-2026) & (USD Million)

Table 97. Middle East & Africa Androgenetic Alopecia Treatment Revenue by Type (2016-2021) & (USD Million)

Table 98. Middle East & Africa Androgenetic Alopecia Treatment Revenue by Type (2021-2026) & (USD Million)

Table 99. Middle East & Africa Androgenetic Alopecia Treatment Revenue by Application (2016-2021) & (USD Million)

Table 100. Middle East & Africa Androgenetic Alopecia Treatment Revenue by Application (2021-2026) & (USD Million)

Table 101. Middle East & Africa Androgenetic Alopecia Treatment Revenue by Country (2016-2021) & (USD Million)

Table 102. Middle East & Africa Androgenetic Alopecia Treatment Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Androgenetic Alopecia Treatment Picture

Figure 2. Global Androgenetic Alopecia Treatment Revenue Market Share by Type in 2020

Figure 3. Topical Agents

Figure 4. 5 AR Inhibitors

Figure 5. Others

Figure 6. Androgenetic Alopecia Treatment Revenue Market Share by Application in 2020

Figure 7. Hospital Pharmacies Picture

Figure 8. Retail Pharmacies Picture

Figure 9. Online Pharmacies Picture

Figure 10. Global Androgenetic Alopecia Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Androgenetic Alopecia Treatment Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Androgenetic Alopecia Treatment Revenue Market Share by Region (2016-2026)

Figure 13. Global Androgenetic Alopecia Treatment Revenue Market Share by Region in 2020

Figure 14. North America Androgenetic Alopecia Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Androgenetic Alopecia Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Androgenetic Alopecia Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Androgenetic Alopecia Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Androgenetic Alopecia Treatment Market Drivers

Figure 19. Androgenetic Alopecia Treatment Market Restraints

Figure 20. Androgenetic Alopecia Treatment Market Trends

Figure 21. Histogen Inc Recent Developments and Future Plans

Figure 22. Cipla Limited Recent Developments and Future Plans

Figure 23. Aclaris Therapeutics, Inc Recent Developments and Future Plans

Figure 24. Merck & Co., Inc Recent Developments and Future Plans

Figure 25. Daiichi-Sankyo Co., Ltd Recent Developments and Future Plans

Figure 26. Johnson and Johnson Services, Inc Recent Developments and Future Plans

Figure 27. Lexington International LLC Recent Developments and Future Plans

Figure 28. Vita-Cos-Med Klett-Loch GmbH Recent Developments and Future Plans

Figure 29. PureTech Recent Developments and Future Plans

Figure 30. Vitabiotics Recent Developments and Future Plans

Figure 31. Dr. Reddy’s Laboratories Recent Developments and Future Plans

Figure 32. HCell Inc Recent Developments and Future Plans

Figure 33. Follica, Inc Recent Developments and Future Plans

Figure 34. Ranbaxy Laboratories Ltd. Recent Developments and Future Plans

Figure 36. Global Androgenetic Alopecia Treatment Revenue Share by Players in 2020

Figure 37. Androgenetic Alopecia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Androgenetic Alopecia Treatment Revenue Market Share in 2020

Figure 39. Global Top 10 Players Androgenetic Alopecia Treatment Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Androgenetic Alopecia Treatment Revenue Share by Type in 2020

Figure 42. Global Androgenetic Alopecia Treatment Market Share Forecast by Type (2021-2026)

Figure 43. Global Androgenetic Alopecia Treatment Revenue Share by Application in 2020

Figure 44. Global Androgenetic Alopecia Treatment Market Share Forecast by Application (2021-2026)

Figure 45. North America Androgenetic Alopecia Treatment Sales Market Share by Type (2016-2026)

Figure 46. North America Androgenetic Alopecia Treatment Sales Market Share by Application (2016-2026)

Figure 47. North America Androgenetic Alopecia Treatment Revenue Market Share by Country (2016-2026)

Figure 48. United States Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Androgenetic Alopecia Treatment Sales Market Share by Type (2016-2026)

Figure 52. Europe Androgenetic Alopecia Treatment Sales Market Share by Application (2016-2026)

Figure 53. Europe Androgenetic Alopecia Treatment Revenue Market Share by Country (2016-2026)

Figure 54. Germany Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Androgenetic Alopecia Treatment Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Androgenetic Alopecia Treatment Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Androgenetic Alopecia Treatment Revenue Market Share by Region (2016-2026)

Figure 62. China Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Androgenetic Alopecia Treatment Sales Market Share by Type (2016-2026)

Figure 69. South America Androgenetic Alopecia Treatment Sales Market Share by Application (2016-2026)

Figure 70. South America Androgenetic Alopecia Treatment Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Androgenetic Alopecia Treatment Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Androgenetic Alopecia Treatment Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Androgenetic Alopecia Treatment Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Androgenetic Alopecia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source